Get started
Author

Paola Zanaga

Observed names: P Zanaga, P. Zanaga
ORCID: 0000-0001-7193-4335
Observed ORCID: 0000-0001-7193-4335
OpenAlex ID: A5044379787
Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis
2023 · Alberto Zanetto, Elena Campello, et al. · Journal of Thrombosis and Haemostasis · 39
PDF
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
2024 · Georg Semmler, Sonia Alonso López, et al. · Journal of Hepatology · 32
Incidence and Clinical Significance of Recompensation After HCV Cure
2025 · Georg Semmler, Sabela Lens, et al. · Clinical Gastroenterology and Hepatology · 20
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
2024 · Georg Semmler, Sonia Alonso López, et al. · Hepatology · 16
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
2023 · André Lopes Simão, Carolina Santos Palma, et al. · JHEP Reports · 14
PDF
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
2023 · Gautam Mehta, Antonio Riva, et al. · Hepatology Communications · 6
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study
2025 · Elisa Pinto, Elisabetta Lazzarini, et al. · Cancers · 4
In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment
2024 · Alberto Ferrarese, Paola Zanaga, et al. · Alimentary Pharmacology & Therapeutics · 4
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort
2021 · Maria Giovanna Quaranta, Luigina Ferrigno, et al. · Digestive and Liver Disease · 4
PDF
Effectiveness, Safety and Patient‐Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real‐World Evidence From a Prospective Observational Study
2026 · Daniele Mengato, Sara Battistella, et al. · Journal of Viral Hepatitis · 1
Whole blood thrombin generation improves the understanding of cirrhotic coagulopathy and predicts clinical outcomes in patients with cirrhosis: a prospective cohort study
2024 · A. Zanetto, E. Campello, et al. · Digestive and Liver Disease · 1
A prospective multicenter study to examine the impact of acquired and genetic predictors on Hepatocellular carcinoma risk in patients with advanced NAFLD: first report
2023 · Serena Pelusi, Cristiana Bianco, et al. · Journal of Hepatology · 1
Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure
2023 · Georg Semmler, Sonia Alonso Lopez, et al. · Journal of Hepatology · 1
The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure
2023 · Georg Semmler, Sonia Alonso Lopez, et al. · Journal of Hepatology · 1
WED-156 A prospective multicenter study to examine the impact of acquired and genetic predictors on hepatocellular carcinoma risk in patients with advanced metabolic associated steatotic liver disease
2026 · Stefania Mira, Serena Pelusi, et al. · Journal of Hepatology
WED-198 Incidence and clinical significance of recompensation after HCV- cure
2025 · Georg Semmler, Sabela Lens, et al. · Journal of Hepatology
WED-289 Patient centered-outcomes in HDV-treated patients with Bulevirtide
2025 · Daniele Mengato, Alessandro Cadore, et al. · Journal of Hepatology
WED-138-YI Somatic copy number alterations in circulating cell-free DNA as a predictive biomarker for hepatocellular carcinoma: insights from a proof-of-concept study
2025 · Elisa Pinto, Elisabetta Lazzarini, et al. · Journal of Hepatology
Rekompensation nach HCV-Heilung
2025 · G Semmler, S Lens, et al. · Zeitschrift für Gastroenterologie
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults
2025 · Tobias Laue, Maria Pilar Ballester, et al. · Transplantation Direct
Oc.10.4 Somatic Copy Number Alterations in Circulating Cell-free Dna as a Predictive Biomarker for Hepatocellular Carcinoma: Insights From a Proof-of-concept Study
2025 · E. Pinto, E. Lazzarini, et al. · Digestive and Liver Disease
Somatic copy number alterations in circulating cell-free DNA as a predictive biomarker for hepatocellular carcinoma: insights from a proof-of-concept study
2025 · E. Pinto, E. Lazzarini, et al. · Digestive and Liver Disease
THU-381 Prognostic implications of liver stiffness impairment after HCV cure in cACLD patients
2024 · Monica Pons, Georg Semmler, et al. · Journal of Hepatology
TOP-061-YI Whole blood thrombin generation improves the understanding of cirrhotic coagulopathy and predicts clinical outcomes in patients with cirrhosis: a prospective cohort study
2024 · Alberto Zanetto, Elena Campello, et al. · Journal of Hepatology
FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
2024 · María Pilar Ballester, Tobias Laue, et al. · Journal of Hepatology
Works count: 28
Citation count: 144
H-index: 6
I10-index: 5
Year
Topic
Type